Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris J O'Callaghan

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Acta Dermato-Venereologica|August 21, 2003
Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot studyCamilo Diaz, Chris J O'Callaghan, Azra Khan, et al.
Statistical Methods in Medical Research|June 20, 2023
Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributionsYangqing Deng, Dongsheng Tu, Chris J O'Callaghan, et al.
American Journal of Physical Medicine & Rehabilitation|September 26, 2006
Functional status and health-related quality of life during inpatient stroke rehabilitationSharen Madden, Wilma M Hopman, Stephen Bagg, et al.
Journal of Geriatric Oncology|September 2, 2019
Accrual of older adults to cancer clinical trials led by the Canadian cancer trials group - Is trial design a barrier?Catalina Hernandez-Torres, Winson Y Cheung, Shiying Kong, et al.
Statistics in Medicine|March 31, 2023
A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomesYangqing Deng, Dongsheng Tu, Chris J O'Callaghan, et al.
Circulation|May 5, 2004
Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individualsHarpal S Randeva, Krzysztof C Lewandowski, Jan Komorowski, et al.
Molecular Genetics and Metabolism|December 19, 2003
Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacementKrzysztof C Lewandowski, Robert D Murray, J Drzewoski, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Differential effects of GH replacement on the components of the leptin system in GH-deficient individualsHarpal S Randeva, Robert D Murray, Krzysztof C Lewandowski, et al.
Acta Oncologica (Stockholm, Sweden)|February 6, 2014
The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17Dirkje W Sommeijer, Christos S Karapetis, John R Zalcberg, et al.
Cancer Medicine|October 25, 2022
Clustering on longitudinal quality-of-life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trialJiahui Zhang, Weili Kong, Pingzhao Hu, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Acta Dermato-Venereologica|August 21, 2003
Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot studyCamilo Diaz, Chris J O'Callaghan, Azra Khan, et al.
Statistical Methods in Medical Research|June 20, 2023
Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributionsYangqing Deng, Dongsheng Tu, Chris J O'Callaghan, et al.
American Journal of Physical Medicine & Rehabilitation|September 26, 2006
Functional status and health-related quality of life during inpatient stroke rehabilitationSharen Madden, Wilma M Hopman, Stephen Bagg, et al.
Journal of Geriatric Oncology|September 2, 2019
Accrual of older adults to cancer clinical trials led by the Canadian cancer trials group - Is trial design a barrier?Catalina Hernandez-Torres, Winson Y Cheung, Shiying Kong, et al.
Statistics in Medicine|March 31, 2023
A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomesYangqing Deng, Dongsheng Tu, Chris J O'Callaghan, et al.
Circulation|May 5, 2004
Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individualsHarpal S Randeva, Krzysztof C Lewandowski, Jan Komorowski, et al.
Molecular Genetics and Metabolism|December 19, 2003
Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacementKrzysztof C Lewandowski, Robert D Murray, J Drzewoski, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Differential effects of GH replacement on the components of the leptin system in GH-deficient individualsHarpal S Randeva, Robert D Murray, Krzysztof C Lewandowski, et al.
Acta Oncologica (Stockholm, Sweden)|February 6, 2014
The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17Dirkje W Sommeijer, Christos S Karapetis, John R Zalcberg, et al.
Cancer Medicine|October 25, 2022
Clustering on longitudinal quality-of-life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trialJiahui Zhang, Weili Kong, Pingzhao Hu, et al.
Pageof 4